Private company
Skorpios Trust
Last updated Oct 21, 2026.
Overview
- HeadquartersG41
Corporate structure
Skorpios Trust sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Skorpios Trust G4
- Akero Therapeutics, Inc. Stake · San Francisco, California, United States
- Stoke Therapeutics, Inc. Stake · Bedford, Massachusetts, United States
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.
Filings
18 filings to the SEC since October 2021: 18 other. The latest 18:
- Oct 29, 202513F-HR EDGAR
- Aug 4, 2025N-PX EDGAR
- Jul 30, 202513F-HR EDGAR
- May 6, 202513F-HR EDGAR
- Feb 5, 202513F-HR EDGAR
- Oct 23, 202413F-HR EDGAR
- Aug 23, 2024N-PX EDGAR
- Aug 5, 202413F-HR EDGAR
- Apr 26, 202413F-HR EDGAR
- Feb 6, 202413F-HR EDGAR
- Nov 6, 202313F-HR EDGAR
- Aug 3, 202313F-HR EDGAR
- May 15, 202313F-HR EDGAR
- Feb 7, 202313F-HR EDGAR
- Nov 7, 202213F-HR EDGAR
- Aug 2, 202213F-HR EDGAR
- Apr 22, 202213F-HR EDGAR
- Jan 27, 202213F-HR EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
Skorpios Trust has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).
- Stoke Therapeutics, Inc.SCHEDULE 13D/A Apr 18, 2024 to Aug 26, 20252
- Akero Therapeutics, Inc.SC 13G/A Dec 5, 2022 to Sep 12, 20233
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSkorpios Trust filings on SEC EDGAR
- 2
- 3